Literature DB >> 22585346

[German adrenocortical carcinoma registry. Surgical therapy results and follow-up treatment].

J Reibetanz1, M Kroiss, T Deutschbein, W Fenske, M Gasser, C Jurowich, C-T Germer, B Allolio, M Fassnacht.   

Abstract

Adrenocortical carcinoma (ACC) is a highly aggressive endocrine disease with an incidence of 1-2 cases per million population per year. Due to the low incidence of ACC knowledge concerning the surgical management is mainly based on retrospective studies or recommendations of isolated experts. Cancer databases, such as the German ACC registry are prerequisite to collect and evaluate clinical data from a large number of patients. For non-metastatic tumor stages, complete tumor resection is the only treatment with curative intent. Open surgery remains the recommended approach for ACC. However, in small tumors with uncertain malignancy a laparoscopic resection by an expert surgeon can be considered. A loco-regional lymphadenectomy should be part of the primary surgical treatment of ACC. Tumor recurrence is common even after an apparently complete primary resection. Therefore, based on the individual risk (tumor size, resection status, proliferation index) adjuvant mitotane treatment is recommended in most patients. Patients with low-risk should be included in the ADIUVO trial. In case of tumor relapse indications for a reoperation should be strongly considered, especially when the time interval since the primary surgery is long (> 12 months) and a complete resection of the recurrent disease seems to be feasible.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22585346     DOI: 10.1007/s00104-011-2193-6

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  28 in total

Review 1.  Recommendation for standardized surgical management of primary adrenocortical carcinoma.

Authors:  Sébastien Gaujoux; Murray F Brennan
Journal:  Surgery       Date:  2012-02-04       Impact factor: 3.982

2.  Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.

Authors:  Ricardo J Gonzalez; Suzanne Shapiro; Nicholas Sarlis; Rena Vassilopoulou-Sellin; Nancy D Perrier; Douglas B Evans; Jeffrey E Lee
Journal:  Surgery       Date:  2005-12       Impact factor: 3.982

3.  Adjuvant and definitive radiotherapy for adrenocortical carcinoma.

Authors:  Aaron Sabolch; Mary Feng; Kent Griffith; Gary Hammer; Gerard Doherty; Edgar Ben-Josef
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-08-01       Impact factor: 7.038

4.  Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.

Authors:  Martin Fassnacht; Stefanie Hahner; Buelent Polat; Ann-Cathrin Koschker; Werner Kenn; Michael Flentje; Bruno Allolio
Journal:  J Clin Endocrinol Metab       Date:  2006-08-08       Impact factor: 5.958

Review 5.  Management of patients with adrenal cancer: recommendations of an international consensus conference.

Authors:  D E Schteingart; G M Doherty; P G Gauger; T J Giordano; G D Hammer; M Korobkin; F P Worden
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

Review 6.  A debate on laparoscopic versus open adrenalectomy for adrenocortical carcinoma.

Authors:  Francesco Porpiglia; Barbra S Miller; Matteo Manfredi; Cristian Fiori; Gerard M Doherty
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

7.  Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients.

Authors:  David Brix; Bruno Allolio; Wiebke Fenske; Ayman Agha; Henning Dralle; Christian Jurowich; Peter Langer; Thomas Mussack; Christoph Nies; Hubertus Riedmiller; Martin Spahn; Dirk Weismann; Stefanie Hahner; Martin Fassnacht
Journal:  Eur Urol       Date:  2010-06-22       Impact factor: 20.096

8.  Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.

Authors:  P Icard; P Goudet; C Charpenay; B Andreassian; B Carnaille; Y Chapuis; P Cougard; J F Henry; C Proye
Journal:  World J Surg       Date:  2001-07       Impact factor: 3.352

Review 9.  Adrenocortical cancer: pathophysiology and clinical management.

Authors:  Rossella Libè; Amato Fratticci; Jérôme Bertherat
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

10.  An eleven-year experience with adrenocortical carcinoma.

Authors:  R F Pommier; M F Brennan
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

View more
  3 in total

Review 1.  Adrenocortical carcinoma: the management of metastatic disease.

Authors:  André P Fay; Aymen Elfiky; Gabriela H Teló; Rana R McKay; Marina Kaymakcalan; Paul L Nguyen; Anand Vaidya; Daniel T Ruan; Joaquim Bellmunt; Toni K Choueiri
Journal:  Crit Rev Oncol Hematol       Date:  2014-06-04       Impact factor: 6.312

2.  Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome?

Authors:  F Porpiglia; C Fiori; F C Daffara; B Zaggia; A Ardito; R M Scarpa; M Papotti; A Berruti; G V Scagliotti; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-12-22       Impact factor: 4.256

3.  Different Types of Urinary Steroid Profiling Obtained by High-Performance Liquid Chromatography and Gas Chromatography-Mass Spectrometry in Patients with Adrenocortical Carcinoma.

Authors:  L I Velikanova; Z R Shafigullina; A A Lisitsin; N V Vorokhobina; K Grigoryan; E A Kukhianidze; E G Strelnikova; N S Krivokhizhina; L M Krasnov; E A Fedorov; I V Sablin; A L Moskvin; E A Bessonova
Journal:  Horm Cancer       Date:  2016-07-01       Impact factor: 3.869

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.